[Federal Register Volume 88, Number 171 (Wednesday, September 6, 2023)]
[Notices]
[Pages 60945-60946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19135]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0076]


Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Advisory Committee on Immunization Practices (ACIP). This meeting 
is open to the public. Time will be available for public comment.

DATES: The meeting will be held on September 22, 2023, 10 a.m. to 5 
p.m., EDT (date and times subject to change; see the ACIP website for 
updates: https://www.cdc.gov/vaccines/acip/index.htm).
    Written comments will be received between September 7-21, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0076, by either of the methods listed below. CDC does not accept 
comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, 
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2023-0076.
    Instructions: All submissions received must include the Agency name 
and docket number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the ACIP website at https://www.cdc.gov/vaccines/acip/index.html.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600

[[Page 60946]]

Clifton Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027. 
Telephone: (404) 639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: Purpose: The Advisory Committee on 
Immunization Practices (ACIP) is charged with advising the Director, 
Centers for Disease Control and Prevention (CDC), on the use of 
immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is 
mandated to establish and periodically review and, as appropriate, 
revise the list of vaccines for administration to vaccine-eligible 
children through the Vaccines for Children program, along with 
schedules regarding dosing interval, dosage, and contraindications to 
administration of vaccines. Further, under applicable provisions of the 
Affordable Care Act and Section 2713 of the Public Health Service Act, 
immunization recommendations of ACIP that have been approved by the 
Director, CDC, and appear on CDC immunization schedules generally must 
be covered by applicable health plans.
    Matters to be Considered: The agenda will include discussions of 
maternal respiratory syncytial virus (RSV) vaccine. A recommendation 
vote for maternal RSV vaccine is scheduled. A Vaccines for Children 
vote is scheduled for maternal RSV vaccine. Agenda items are subject to 
change as priorities dictate. For more information on the meeting 
agenda, visit https://www.cdc.gov/vaccines/acip/meetings/index.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web. For more information on ACIP, please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near-duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on September 7, 2023. Written comments must be 
received by September 21, 2023.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Priority will be given to 
individuals who submit a request to make an oral public comment before 
the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the September 22, 2023, ACIP meeting must 
submit a request between September 7, 2023, and September 20, 2023, at 
https://www.cdc.gov/vaccines/acip/meetings/index.html no later than 
11:59 p.m., EDT, September 20, 2023, according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email on September 21, 2023. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each 
speaker may only speak once per meeting.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-19135 Filed 9-5-23; 8:45 am]
BILLING CODE 4163-18-P